Corporate Banner
Satellite Banner
Medicinal Chemistry
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Thermo Scientific is Featuring New Twin-Screw Extruder at AAPS 2012

Published: Tuesday, October 16, 2012
Last Updated: Tuesday, October 16, 2012
Bookmark and Share
Fully scalable Thermo Scientific Pharma 11 extruder used for pharmaceutical research.

Thermo Fisher Scientific Inc. will feature its new Thermo Scientific Pharma 11 parallel co-rotating twin-screw extruder at the 2012 AAPS conference.

The 11 mm extruder is designed specifically for pharmaceutical applications to minimize material costs, be easier to use and optimize laboratory space.

To achieve this, the benchtop Pharma 11 uses a minimal amount of sample material (20 g) and features a user-friendly touchscreen with integrated feeder control.

To deliver performance as requested by today’s pharma developers, Thermo Fisher, for the first time, offers a complete strandline, containing air-cooled conveyor belt and adjustable pelletizer, all with the convenient footprint of a standard fumehood.

Today’s researchers and scientists face multiple challenges, from resource constraints to limited lab space and budgets. Pharma 11 meets these challenges head-on by delivering a small, simple-to-use and scalable extruder.

“Since its introduction six months ago, our customers have extensively tested Pharma 11 in real-life applications. And, time after time, researchers and scientists have confirmed the tagline ‘Small, Simple, Scalable’ in every aspect,” said Charndeep Khattar, Director product line Process/Pharma Instruments at Thermo Fisher.

Khattar continued, “With its compact footprint and minimal sample material use, Pharma 11 simplifies the testing process and enables scientists to focus on delivering world-class pharmaceutical research. It is no wonder that the number of Pharma 11 extruders deployed worldwide today has exceeded all expectations.”

The new Pharma 11 extruder features a throughput of 20 g/h to 2.5 kg/h and is easily convertible from hot melt extrusion (HME) to twin screw granulation (TSG) applications.

The Pharma 11 extruder is ideal for a wide range of drug development applications including drug delivery systems, implants, tablets and granules.

The GMP-compliant device is also suitable for clinical trials, and the compact design makes it ideal for glove box applications.

Thermo Fisher, one of the pioneers in rheology, successfully supports a wide range of industries with its comprehensive Thermo Scientific material characterization solutions.

Material characterization solutions analyze and measure viscosity, elasticity, process ability and temperature-related mechanical changes of plastics, food, cosmetics, pharmaceuticals and coatings, chemical or petrochemical products, plus a wide variety of liquids or solids.

For more information, please visit www.thermoscientific.com/mc.

Thermo Fisher will showcase the Pharma 11 extruder in Thermo Scientific booth 4519 during the 2012 AAPS conference in Chicago, Oct. 14-18.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Thermo Scientific Screening Library Advances Drug Discovery Research at Temple University’s Moulder Center
20,000-molecule Maybridge collection will help identify compound candidates to treat a wide range of diseases.
Thursday, October 20, 2011
Scientific News
Combining Chemotherapy With Immune-Blocking Drug Could Stop Cancer Growing Back
Giving patients a drug that blocks part of the immune system from going into overdrive might help prevent cancer coming back in some people.
Researchers Pioneer Use of Capsules to Save Materials
Wax capsule delivery systems can simplify a wide range of chemistry transformations.
Photoredox Catalyst Unlocks New Pathways for Nickel Chemistry
Using a light-activated catalyst, researchers have unlocked a new pathway in nickel chemistry to construct carbon-oxygen (C-O) bonds that would be highly valuable to pharmaceutical and agrochemical industries.
Scientists Determine How Antibiotic Gains Cancer-Killing Sulfur Atoms
In a discovery with implications for future drug design scientists have shown an unprecedented mechanism for how a natural antibiotic with antitumor properties incorporates sulfur into its molecular structure, an essential ingredient of its antitumor activity.
Familiar Drugs May Block Ebola Virus Infection
A well-known class of molecules, many of which are already in use therapeutically, may be able to block the Ebola virus’s entry into cells and halt the disease in its tracks, according to researchers at the University of Illinois at Chicago.
New Extra ‘Sticky’ Microgel Could Revolutionise Bladder Cancer Treatment
Researchers have designed a new super-efficient way of delivering an anti-cancer drug which could extend and improve the quality of life for bladder cancer patients - and perhaps save lives.
Common Class of ‘Channel Blocking’ Drugs May Find a Role in Cancer Therapy
Discoveries in fruit flies prompt unusual treatment of patient with metastatic disease.
Common Medications Could Delay Brain Injury Recovery
Drugs used to treat common complaints could delay the recovery of brain injury patients according to research by University of East Anglia (UEA) and University of Aberdeen scientists, published today in Brain Injury.
Scientists Make Strides in Therapy Preventing Addiction Relapse
Single Injection of Drug Candidate Prevents Meth Relapse in Animal Models.
New Clot-Busting Treatments Target Number One Killer
Australian researchers funded by the National Heart Foundation are a step closer to a safer and more effective way to treat heart attack and stroke via nanotechnology.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!